#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
At Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, our care is informed by our research. We have a long history of research and innovation in pediatric oncology. Clinical and basic scientists at Boston Children's Hospital and Dana-Farber Cancer Institute are conducting numerous research studies that will help us better understand and treat pediatric cancers.
We are studying angiogenesis inhibitors, substances that may be able to prevent the growth of tumors.
We are investigating the use of biological therapies, a wide range of substances that may be able to involve the body's own immune system to fight cancer or lessen harmful side effects of some treatments.
Researchers are looking into different chemotherapy drugs that may prove effective in children with alveolar soft part sarcoma.
We are continuously working to reduce the side effects of therapy and determine the optimal treatment strategy for each type of cancer.
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is the New England Phase I Center of the Children's Oncology Group. If your child has progressive or recurrent disease, he may be eligible for a number of experimental therapies available through these groups, or through one of our independent clinical investigators.
The Children's Oncology Group is a consortium of cancer treatment centers across the United States, Canada, and other countries that conduct studies of nearly every kind of pediatric cancer. Our participation in the Children’s Oncology Group gives children with cancer unparalleled access to the newest clinical trials.
Read about our innovative research on the Cancer Care Center page.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”